Ascendis Pharma A/S
Ascendis Pharma's GHG Emissions Data Preview
In 2024, Ascendis Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Ascendis Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Ascendis Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ascendis Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Ascendis Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Ascendis Pharma amounted to 1,109 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Ascendis Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Ascendis Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Ascendis Pharma were 62 metric tons of CO₂ equivalent (tCO₂e). a
What are Ascendis Pharma's Scope 2 emissions?
In 2024, Ascendis Pharma reported Scope 2 greenhouse gas (GHG) emissions of 672 tCO₂e using the market-based method and 1,047 tCO₂e using the location-based method. a
What methodology does Ascendis Pharma use for Scope 2 reporting?
In 2024, Ascendis Pharma reported its Scope 2 emissions using the market-based method and using the location-based method. a
Ascendis Pharma's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Ascendis Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Ascendis Pharma reported Scope 1 greenhouse gas (GHG) emissions of 62 tCO₂e and total revenues of USD 443 millions. This translates into an emissions intensity of 0.14 tCO₂e per millions USD. a
Ascendis Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Ascendis Pharma's GHG emissions intensity compare to its peers?
In 2024, Ascendis Pharma reported a Scope 1 emissions intensity of 0.14 tCO₂e per millions USD. Compared to the peer group median of 4.38, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Ascendis Pharma rank on GHG emissions intensity within its industry?
In 2024, Ascendis Pharma ranked 3 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Ascendis Pharma among the top performers, with one of the lowest emissions intensities relative to peers. a